Monographie - Pentamidine isetionate

Senaste uppdateringen :
08/05/2024

Pentamidine isetionate

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

DBL Pentamidine isetionate	Malaysia
Manicare	Argentina
Nebupent	Förenta Staterna
Pentacarinat	Belgien, Colombia, Danmark, Finland, Frankrike, Grekland, Italien, Luxemburg, Nederländerna, Nya Zeeland, Österrike, Schweiz, Spanien, Storbritannien, Sverige, Tyskland
Pentam	Förenta Staterna
Pentamidina	Argentina, Spanien
Pentamidine isethionate	Australien, Förenta Staterna, Kanada, Malaysia
Pentamina	Portugal

Hänvisningar : Pentamidine isetionate

	Typ	Publikation
36	Tidningen	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Tidningen	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Tidningen	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Tidningen	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Tidningen	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Tidningen	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Tidningen	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratorium	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Tidningen	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Tidningen	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Tidningen	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Tidningen	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratorium	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratorium	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratorium	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratorium	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales